Clavister Q2’20: First Comments
Research Note
2020-08-27
10:31
Redeye will most likely lower current year forecasts, mainly as a result of Covid-19 related project delays. Even if recognised revenue came in short of expectations, strong order intake growth and billings should support growth in the coming quarters. Our base case is SEK 18.0 per share.
HH
Havan Hanna
Disclosures and disclaimers